AU2001270631A2 - Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals - Google Patents

Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals

Info

Publication number
AU2001270631A2
AU2001270631A2 AU2001270631A AU2001270631A AU2001270631A2 AU 2001270631 A2 AU2001270631 A2 AU 2001270631A2 AU 2001270631 A AU2001270631 A AU 2001270631A AU 2001270631 A AU2001270631 A AU 2001270631A AU 2001270631 A2 AU2001270631 A2 AU 2001270631A2
Authority
AU
Australia
Prior art keywords
pharmaceuticals
strains
anticancer
parapox ovis
ovis virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001270631A
Other versions
AU2001270631A1 (en
AU2001270631B2 (en
Inventor
Claudia Hirth-Dietrich
Andreas Knorr
Tobias Schlapp
Angela Siegling
Gudrun Theiss
Hans-Dieter Volk
Olaf Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10122451A external-priority patent/DE10122451A1/en
Application filed by Bayer AG filed Critical Bayer AG
Priority claimed from PCT/EP2001/007991 external-priority patent/WO2002004002A2/en
Publication of AU2001270631A1 publication Critical patent/AU2001270631A1/en
Publication of AU2001270631A2 publication Critical patent/AU2001270631A2/en
Application granted granted Critical
Publication of AU2001270631B2 publication Critical patent/AU2001270631B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

AU2001270631A 2000-07-11 2001-07-11 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals Expired - Fee Related AU2001270631B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10033582 2000-07-11
DE10033582 2000-07-11
DE10122451A DE10122451A1 (en) 2000-07-11 2001-05-09 Use of strains of the Parapoxvirus ovis for the production of antiviral and anti-cancer drugs
DE10122451 2001-05-09
PCT/EP2001/007991 WO2002004002A2 (en) 2000-07-11 2001-07-11 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals

Publications (3)

Publication Number Publication Date
AU2001270631A1 AU2001270631A1 (en) 2002-04-18
AU2001270631A2 true AU2001270631A2 (en) 2003-05-29
AU2001270631B2 AU2001270631B2 (en) 2005-07-07

Family

ID=26006335

Family Applications (2)

Application Number Title Priority Date Filing Date
AU7063101A Pending AU7063101A (en) 2000-07-11 2001-07-11 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticalsand anticancer pharmaceuticals
AU2001270631A Expired - Fee Related AU2001270631B2 (en) 2000-07-11 2001-07-11 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU7063101A Pending AU7063101A (en) 2000-07-11 2001-07-11 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticalsand anticancer pharmaceuticals

Country Status (36)

Country Link
US (1) US6685950B2 (en)
EP (1) EP1303286B1 (en)
JP (1) JP5037775B2 (en)
CN (1) CN1455674B (en)
AR (1) AR029954A1 (en)
AT (1) ATE324115T1 (en)
AU (2) AU7063101A (en)
BG (1) BG107448A (en)
CA (1) CA2415397C (en)
CY (1) CY1105408T1 (en)
CZ (1) CZ200371A3 (en)
DE (1) DE50109630D1 (en)
DK (2) DK1303286T3 (en)
EE (1) EE200300018A (en)
ES (1) ES2262663T3 (en)
FI (1) FI20030037A (en)
GB (1) GB2381454B8 (en)
HK (1) HK1054329B (en)
HR (1) HRP20030096A2 (en)
HU (1) HUP0400479A3 (en)
IL (1) IL153643A0 (en)
LT (1) LT5079B (en)
LU (1) LU90997B1 (en)
LV (1) LV12990B (en)
MA (1) MA26927A1 (en)
MX (1) MXPA03000279A (en)
NO (1) NO20030082D0 (en)
NZ (1) NZ523534A (en)
PL (1) PL366397A1 (en)
PT (1) PT1303286E (en)
RU (1) RU2003104525A (en)
SE (1) SE0300034L (en)
SI (1) SI21122A (en)
SK (1) SK362003A3 (en)
UY (1) UY26832A1 (en)
WO (1) WO2002004002A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19922407A1 (en) * 1999-05-14 2000-11-16 Bayer Ag Preparing medicament for treating viral infections, liver diseases or cancer, comprising recombinant parapoxvirus targeted towards specific organs, cells or tissues
US7097842B2 (en) * 2000-11-23 2006-08-29 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
EP1598425A1 (en) * 2000-11-23 2005-11-23 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant
US7628980B2 (en) * 2000-11-23 2009-12-08 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
NZ512341A (en) 2001-06-13 2004-02-27 Bayer Ag Polynucleotides between 15 and 100 base pairs in length coding for parapoxvirus ovis (PPVO)/vaccinia virus recombinant (VVOV) viral genome fragments
AU2002353031A1 (en) 2001-12-07 2003-06-23 Bayer Corporation Use of parapox b2l protein to treat cancer and modify immune responses
ES2288609T5 (en) * 2002-04-19 2017-11-13 Bavarian Nordic A/S Modified vaccinia ankara virus for the vaccination of neonates
PL215169B1 (en) * 2002-09-05 2013-10-31 Bavarian Nordic As Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
CN103800382A (en) * 2004-07-13 2014-05-21 爱库里斯股份有限两合公司 Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids
EP1951274B1 (en) * 2005-11-24 2009-12-02 AiCuris GmbH & Co. KG Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer
JP5004990B2 (en) * 2009-03-31 2012-08-22 アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト Recombinant protein of parapoxvirus Ovis and pharmaceutical composition derived therefrom
DK2513311T4 (en) * 2009-12-18 2021-06-14 Bavarian Nordic As PRODUCTION OF IFN-LAMBDA BY TRADITIONAL DENDRIT CELLS AND USES THEREOF
JP5699093B2 (en) * 2012-01-05 2015-04-08 アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフトＡｉＣｕｒｉｓ ＧｍｂＨ ＆ Ｃｏ． ＫＧ Recombinant protein of parapoxvirus Ovis and pharmaceutical composition derived therefrom
TW201919675A (en) * 2017-09-07 2019-06-01 德商艾庫瑞斯公司 Combination therapies of hepatitis B virus (HBV)-infected individuals using Parapoxvirus ovis (PPVO) and at least one further antiviral drug
WO2023083950A1 (en) * 2021-11-10 2023-05-19 Aicuris Gmbh & Co. Kg Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with immunomodulators
WO2023083943A1 (en) * 2021-11-10 2023-05-19 Aicuris Gmbh & Co. Kg Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with antivirals

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (en) * 1977-04-01 1978-10-05 Mayr Anton PREPARATION FOR TREATING HERPES ZOSTER AND OTHER HERPES INFECTIONS AND METHOD FOR THE PRODUCTION THEREOF
DE3504940C2 (en) * 1984-02-17 1997-11-06 Bayer Ag Multipotent paramunity mediators, processes for their preparation and medicaments containing these mediators
US5443964A (en) * 1987-08-10 1995-08-22 Duke University Poxvirus insertion/expression vector
DE4405841C1 (en) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotent non-specific immunity inducers based on combinations of poxvirus components, processes for their preparation and their use as pharmaceuticals
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
WO1997032029A1 (en) * 1996-02-28 1997-09-04 Bayer Aktiengesellschaft Parapoxviruses containing foreign dna, their production and their use in vaccines
CA2250041A1 (en) * 1996-03-29 1997-10-09 University Of Otago Parapoxvirus vectors
PT885013E (en) * 1996-04-15 2002-01-30 Anton Mayr Prof Dr Med Vet Dr USE OF MULTI-POTENTIAL INDUCTORS BASED ON POXVIRUSES OR PARAPOXVIRUS ATENUATED AND NOT IMMUNOGENIC FOR THE MANUFACTURE OF MEDICINES
SE9700617D0 (en) * 1997-02-21 1997-02-21 Kjell Alving New composition
DE19843222A1 (en) * 1998-09-22 2000-03-30 Hassan Jomaa Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections
NZ511119A (en) * 1998-11-02 2004-04-30 Ludwig Inst Cancer Res Vascular endothelial growth factor-like protein from ORF virus NZ2 binds and activates mammalian VEGF receptor-2

Similar Documents

Publication Publication Date Title
AU2001270631A2 (en) Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
AU2001270631A1 (en) Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
GB0302630D0 (en) Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
AU2001244675A1 (en) Aids virus vaccine with the use of sendai virus vector
AU6625400A (en) Catalyst preparation and epoxidation process
AU2002223470A1 (en) Modulation of the transcription of pro-inflammatory gene products
AU2002225509A1 (en) Production and of viruses, viral isolates and vaccines
AU5368699A (en) Derivatives of triptolide, and preparation and uses thereof
AU5428700A (en) Acrylic acid derivatives, use of the same and intermediates for the preparation thereof
AU2001285827A2 (en) Use of strains of the parapox ovis virus against organ fibrosis
AU2001285827A1 (en) Use of strains of the parapox ovis virus against organ fibrosis
LU90996B1 (en) Use of the strains of the parapox ovis virus against fibrosis
AU5277199A (en) Supergravitational field vortex reactor and the use thereof
AU3714800A (en) Hiv therapy
AU2960000A (en) Detection of human immunodeficiency virus
AU2002314274A1 (en) Vaccination against the feline immunodeficiency virus
AU2488600A (en) Endophyte and grass infected by the same
AU1223699A (en) Aluminium acetoacetate compounds, the production and use thereof as printing inkadditives
AU782659C (en) Herpes virus strains for gene therapy
GB0100430D0 (en) Virus strains
GB0100288D0 (en) Virus strains
AU2002315934A1 (en) Process of lactonization in the preparation of statins
GB0011221D0 (en) Viral preparations and their production and use
AU2002319163A1 (en) Cyanoanthranilamide derivatives and the use thereof as medicaments